1 / 20

Costs of chronic kidney disease

Costs of chronic kidney disease. USRDS 2008 Annual Data Report. Patient & cost distributions for CKD, diabetes, & congestive heart failure, 2006 Figure 5.1 (Volume 1).

dalit
Télécharger la présentation

Costs of chronic kidney disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Costs of chronic kidney disease USRDS 2008 Annual Data Report

  2. Patient & cost distributions for CKD, diabetes, & congestive heart failure, 2006Figure 5.1 (Volume 1) Medicare: period prevalent patients, age 65 & older, without ESRD. Medstat & Ingenix i3: period prevalent patients, age 50–64, enrolled in a fee-for-service plan, & without ESRD. CHF, diabetes, & CKD determined from claims, & costs are for calendar year 2006.

  3. Patient & cost distributions for CKD, diabetes, & congestive heart failure, 2006Figure 5.1 (Volume 1) Medicare: period prevalent patients, age 65 & older, without ESRD. Medstat & Ingenix i3: period prevalent patients, age 50–64, enrolled in a fee-for-service plan, & without ESRD. CHF, diabetes, & CKD determined from claims, & costs are for calendar year 2006.

  4. Expenditures for CKD, by datasetFigure 5.2 (Volume 1) Medicare: period prevalent general Medicare patients age 65 & older, with Medicare as primary payor, & not enrolled in Medicare Advantage. Medstat: period prevalent patients age 50–64, enrolled in a fee-for-service plan. CHF, diabetes, & CKD determined from claims.

  5. Overall PPPM costs for CKD, by datasetFigure 5.3 (Volume 1) Medicare: period prevalent general Medicare patients age 65 & older, with Medicare as primary payor, & not enrolled in Medicare Advantage. Medstat: period prevalent patients age 50–64, enrolled in a fee-for-service plan. CHF, diabetes, & CKD determined from claims. Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire cost-year follow-up time.

  6. Per person per month CKD expenditures, by diagnosis & datasetFigure 5.4 (Volume 1) Medicare: period prevalent general Medicare patients age 65 & older, with Medicare as primary payor, & not enrolled in Medicare Advantage. Medstat: period prevalent patients age 50–64, enrolled in a fee-for-service plan. CHF, diabetes, & CKD determined from claims. Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire cost-year follow-up time.

  7. PPPM costs during the transition to ESRD, by datasetFigure 5.5 (Volume 1) Medicare: patients age 67 & older, initiating ESRD therapy in 2005, & with Medicare as primary payor (not enrolled in Medicare Advantage). Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire transition period. Medstat: patients younger than 65, initiating ESRD therapy in 2005, & enrolled for the entire transition period.

  8. PPPM inpatient costs during the transition to ESRDFigure 5.6 (Volume 1) Medicare: patients age 67 & older, initiating ESRD therapy in 2005, & with Medicare as primary payor (not enrolled in Medicare Advantage). Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire transition period. Medstat: patients younger than 65, initiating ESRD therapy in 2005, & enrolled for the entire transition period.

  9. PPPM cardiovascular hosp. costs during the transition to ESRDFigure 5.7 (Volume 1) Medicare: patients age 67 & older, initiating ESRD therapy in 2005, & with Medicare as primary payor (not enrolled in Medicare Advantage). Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire transition period. Medstat: patients younger than 65, initiating ESRD therapy in 2005, & enrolled for the entire transition period. Hospitalization cause determined using principal diagnosis code for all groups.

  10. PPPM inpatient/outpatient net costs ($) for CKD, 2006Table 5.a (Volume 1) Medicare: period prevalent general Medicare patients age 65 & older, with Medicare as primary payor, & not enrolled in Medicare Advantage. Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire cost-year follow-up time. Medstat: period prevalent patients age 50–64, enrolled in a fee-for-service plan. CHF, diabetes, & CKD determined from claims, & PPPM costs are for calendar year 2006, with actuarial categories determined by place of service; CPT, revenue, & HCPCS codes; & provider specialty. Oral prescription drugs (not present for Medicare) are included in the outpatient pharmacy category.

  11. PPPM physician/supplier net costs ($) for CKD, 2006Table 5.a (Volume 1) (continued) Medicare: period prevalent general Medicare patients age 65 & older, with Medicare as primary payor, & not enrolled in Medicare Advantage. Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire cost-year follow-up time. Medstat: period prevalent patients age 50–64, enrolled in a fee-for-service plan. CHF, diabetes, & CKD determined from claims, & PPPM costs are for calendar year 2006, with actuarial categories determined by place of service; CPT, revenue, & HCPCS codes; & provider specialty. Oral prescription drugs (not present for Medicare) are included in the outpatient pharmacy category.

  12. Per person per month inpatient & outpatient net costs for CKD, by datasetFigure 5.8 (Volume 1) Medicare: period prevalent general Medicare patients age 65 & older, with Medicare as primary payor, & not enrolled in Medicare Advantage. Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire cost-year follow-up time. Medstat: period prevalent patients age 50–64, enrolled in a fee-for-service plan. CHF, diabetes, & CKD determined from claims, & PPPM costs are for calendar year 2006, with actuarial categories determined by place of service; CPT, revenue, & HCPCS codes; & provider specialty. Oral prescription drugs (not present for Medicare) are included in the outpatient pharmacy category. populations: CKD, diabetes, & CKD determined from claims. Costs are PPPM inpatient plus outpatient costs, & do not include skilled nursing facility, home health, or hospice.

  13. Per person per month physician/supplier net costs for CKDFigure 5.9 (Volume 1) Medicare: period prevalent general Medicare patients age 65 & older, with Medicare as primary payor, & not enrolled in Medicare Advantage. Dually-enrolled: a subset of the Medicare population; includes patients dually-enrolled for the entire cost-year follow-up time. Medstat: period prevalent patients age 50–64, enrolled in a fee-for-service plan. CHF, diabetes, & CKD determined from claims, & PPPM costs are for calendar year 2006, with actuarial categories determined by place of service; CPT, revenue, & HCPCS codes; & provider specialty. Oral prescription drugs (not present for Medicare) are included in the outpatient pharmacy category. CKD, diabetes, & CKD determined from claims. Costs are PPPM physician/supplier.

  14. Actual & predicted costs per member per month for Medicare CKD patients, by age & diagnosis: MalesTable 5.b (Volume 1) prevalent general Medicare patients, not enrolled in an HMO, without ESRD, & surviving in 2005. Medicare payments in 2006 include inpatient, skilled nursing, home health, outpatient, physician/supplier, & durable medical equipment. Diagnosis groups based on M+C risk adjustment model (see www.cms.gov). Actual PPPM cost not weighted by follow up time. Definitions for CKD, diabetes, & CHF are based on the CMS-HCC model, i.e., defined if there is any diagnosis code. HCC: hierarchical condition category.

  15. Actual & predicted costs per member per month for Medicare CKD patients, by age & diagnosis: FemalesTable 5.b (Volume 1) (continued) prevalent general Medicare patients, not enrolled in an HMO, without ESRD, & surviving in 2005. Medicare payments in 2006 include inpatient, skilled nursing, home health, outpatient, physician/supplier, & durable medical equipment. Diagnosis groups based on M+C risk adjustment model (see www.cms.gov). Actual PPPM cost not weighted by follow up time. Definitions for CKD, diabetes, & CHF are based on the CMS-HCC model, i.e., defined if there is any diagnosis code. HCC: hierarchical condition category.

  16. Actual & predicted costs per member per month for Medicare CKD patients, by age & diagnosis: AllTable 5.b (Volume 1) (continued) prevalent general Medicare patients, not enrolled in an HMO, without ESRD, & surviving in 2005. Medicare payments in 2006 include inpatient, skilled nursing, home health, outpatient, physician/supplier, & durable medical equipment. Diagnosis groups based on M+C risk adjustment model (see www.cms.gov). Actual PPPM cost not weighted by follow up time. Definitions for CKD, diabetes, & CHF are based on the CMS-HCC model, i.e., defined if there is any diagnosis code. HCC: hierarchical condition category.

  17. Annualized actual costs for Medicare CKD patients, 2006Figure 5.10 (Volume 1) prevalent general Medicare patients, not enrolled in an HMO, without ESRD, & surviving in 2005. Medicare payments in 2006 include inpatient, skilled nursing, home health, outpatient, physician/supplier, & durable medical equipment. Diagnosis groups based on M+C risk adjustment model (see www.cms.gov). Actual PPPM cost not weighted by follow up time. Definitions for CKD, diabetes, & CHF are based on the CMS-HCC model, i.e., defined if there is any diagnosis code. HCC: hierarchical condition category.

  18. Annualized predicted costs for Medicare CKD patients (2007 CMS-HCC model), 2006Figure 5.11 (Volume 1) prevalent general Medicare patients, not enrolled in an HMO, without ESRD, & surviving in 2005. Medicare payments in 2006 include inpatient, skilled nursing, home health, outpatient, physician/supplier, & durable medical equipment. Diagnosis groups based on M+C risk adjustment model (see www.cms.gov). Actual PPPM cost not weighted by follow up time. Definitions for CKD, diabetes, & CHF are based on the CMS-HCC model, i.e., defined if there is any diagnosis code. HCC: hierarchical condition category.

  19. Ratios of AAPCC & HCC predicted PPPM costs to actual PPPM costs in Medicare CKD patientsTable 5.c (Volume 1) prevalent general Medicare patients, not enrolled in an HMO, without ESRD, & surviving in 2005. Medicare payments in 2006 include inpatient, skilled nursing, home health, outpatient, physician/supplier, & durable medical equipment. Diagnosis groups based on M+C risk adjustment model (see www.cms.gov). Actual PPPM cost not weighted by follow up time. Definitions for CKD, diabetes, & CHF are based on the CMS-HCC model, i.e., defined if there is any diagnosis code. HCC: hierarchical condition category.

  20. Predicted costs per person per month for Medicare CKD patients: 2006 CMS-HCC vs. 2007 CMS-HCC modelFigure 5.12 (Volume 1) 1: Non-CKD 2: CKD (NDM, non-CHF) 3: CKD + DM 4: CKD + CHF 5: CKD + DM + CHF prevalent general Medicare patients, not enrolled in an HMO, without ESRD, & surviving in 2005. Medicare payments in 2006 include inpatient, skilled nursing, home health, outpatient, physician/supplier, & durable medical equipment. Diagnosis groups based on M+C risk adjustment model (see www.cms.gov). Actual PPPM cost not weighted by follow up time. Definitions for CKD, diabetes, & CHF are based on the CMS-HCC model, i.e., defined if there is any diagnosis code. HCC: hierarchical condition category.

More Related